vimarsana.com

Latest Breaking News On - Ivy capital management - Page 2 : vimarsana.com

Seven Eight Capital LP Sells 35,765 Shares of CNX Resources Co (NYSE:CNX)

Seven Eight Capital LP lessened its stake in shares of CNX Resources Co. (NYSE:CNX – Free Report) by 25.6% during the 4th quarter, Holdings Channel reports. The fund owned 103,678 shares of the oil and gas producer’s stock after selling 35,765 shares during the period. Seven Eight Capital LP’s holdings in CNX Resources were worth […]

Keeley Teton Advisors LLC Sells 22,787 Shares of Air Lease Co (NYSE:AL)

Keeley Teton Advisors LLC lowered its holdings in Air Lease Co. (NYSE:AL – Free Report) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,447 shares of the transportation company’s stock after selling 22,787 shares during the […]

Stanley Black & Decker, Inc (NYSE:SWK) Shares Sold by Clean Energy Transition LLP

Clean Energy Transition LLP lowered its stake in shares of Stanley Black & Decker, Inc. (NYSE:SWK – Free Report) by 3.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,207,011 shares of the industrial products company’s stock after selling 85,320 shares during the quarter. Stanley Black & Decker accounts for 21.5% of Clean […]

Rhenman & Partners Asset Management AB Buys 39,000 Shares of Axsome Therapeutics, Inc (NASDAQ:AXSM)

Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […]

Rhenman & Partners Asset Management AB Cuts Position in Intra-Cellular Therapies, Inc (NASDAQ:ITCI)

Rhenman & Partners Asset Management AB reduced its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,000 shares of the biopharmaceutical company’s stock after selling 5,000 shares during the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.